Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill

Infect Disord Drug Targets. 2023;23(4):e240223214000. doi: 10.2174/1871526523666230224094439.

Ziad Fajloun^{1

2}, Ziad Abi Khattar^{3

4}, Hervé Kovacic⁵, Christian Legros⁶, Jean-Marc Sabatier⁵

¹ Department of Biology, Faculty of Sciences 3, Lebanese University, Campus Michel Slayman Ras Maska, Tripoli 1352, Lebanon.
² Laboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and its Applications, EDST, Lebanese University, Tripoli 1300, Lebanon.
³ Laboratory of Georesources, Geosciences and Environment (L2GE), Microbiology/Tox-Ecotoxicology Team, Faculty of Sciences 2, Lebanese University, Campus Fanar, Jdeidet El-Matn, Beirut, P.O. Box 90656, Lebanon.
⁴ Department of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos Campus, Byblos, P.O. Box 36, Lebanon.
⁵ The Institute of Neurophysiopathology, Aix-Marseille University, CNRS, INP, Marseille 13385, France.
⁶ University of Angers, INSERM, CNRS, MITOVASC, Team 2 CarMe, SFR ICAT, Angers 49000, France.

No abstract available

Publication types